CClinicalTrials.gg
RecruitingNCT06208332Updated Feb 18, 2026

The "What Is Important to Us" Communication Intervention Pilot Clinical Trial

A Phase 2 interventional study of "What Is Important to Us" Communication Intervention in Critical Illness and Neurologic Disorder, sponsored by Seattle Children's Hospital. Recruiting at 1 site in United States. Open to participants aged 6 Months and older. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by Seattle Children's Hospital · Phase 2, Interventional, and Supportive care

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 7 months later.
Phase
Phase 2
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
6 Months and older
Sex
All
01

Study summary

The objective of this study is to conduct a pilot randomized controlled trial (RCT) of a photo-narrative communication intervention developed by our study team with patients/parents of children with severe neurological impairment (SNI) and their pediatric intensive care unit (PICU) clinicians to assess feasibility, acceptability, and early efficacy.

Read the detailed description

Pilot randomized controlled trial of the "What Is Important to Us" communication intervention. Parents of children with severe neurological impairment in the ICU and their clinicians will be enrolled at the time of the child's ICU admission (baseline) and complete pre-intervention surveys before randomization. Intervention-arm parents and clinicians will complete the "What Is Important to Us" intervention. Post-intervention (within 1 week of ICU discharge) surveys will be completed by parents and clinicians. The control-arm parents will receive usual care (including standard psychosocial supports such as social work). Control-arm parents and clinicians will complete study surveys at the same timepoints. Semi-structured interviews will be completed with intervention-arm parents and clinicians following survey completion to guide further intervention enhancements and future work.

02

Conditions studied

  • Critical Illness
  • Neurologic Disorder

Keywords

  • pediatric palliative care
  • communication
  • severe neurological impairment
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's planned enrollment of 160 is above the median of 90 across 979 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Seattle Children's Hospital is the lead sponsor of 210 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Children with SNI

Inclusion

  • Hospitalized at study sites
  • Ages 6 months through 25 years old
  • Has had SNI for >6 months, defined as permanent static or progressive central nervous system injury resulting in motor/cognitive impairment and medical complexity

Exclusion

  • Has never previously been home/discharged
  • Has an expected hospital length of stay \<2 days
  • Has a life expectancy of \<4 weeks
  • Previous study participation

Parents

Inclusion

  • Parent/legally authorized representative of an eligible child with SNI
  • Preferred language of care English and/or Spanish

Clinicians

Inclusion -Licensed physicians, nurses, advanced practice providers, respiratory therapists at study site

Exclusion

-Previous study participation

05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    "What Is Important to US" Communication Intervention

    The "What Is Important to Us" intervention is a photo-narrative invention that prompts parents to select a total of 1-3 photos that are then displayed at their child's ICU bedside representing: 1) who is important in our family; 2) what strengthens us as parents; 3) how we know our child is feeling well; and 4) what makes our child's hospitalization easier. Parents are encouraged to discuss the pictures with clinicians caring for their child. Clinicians caring for the child are sent the photos electronically along with suggested discussion prompts to use with parents.

    Behavioral: "What Is Important to Us" Communication Intervention

  • No intervention
    Usual Care

    Usual supportive care

Interventions

  • Behavioral"What Is Important to Us" Communication Intervention

    The "What Is Important to Us" intervention is a photo-narrative invention that prompts parents to select a total of 1-3 photos that are then displayed at their child's ICU bedside representing: 1) who is important in our family; 2) what strengthens us as parents; 3) how we know our child is feeling well; and 4) what makes our child's hospitalization easier. Parents are encouraged to discuss the pictures with clinicians caring for their child. Clinicians caring for the child are sent the photos electronically along with suggested discussion prompts to use with parents..

06

What researchers measure

Primary outcomes

  1. Feasibility

    Feasibility will be set at a benchmark of 70% and assessed by calculating: 1) the percent enrolled (total enrolled/total approached), plus a 95% confidence interval; and 2) the percent completion (parents completing intervention/total in intervention arm), plus a 95% confidence interval.

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

  2. Acceptability

    Acceptability will be set at a benchmark of 70% and assessed by computing the intervention recommendation percent (total number of intervention parents likely to very likely to recommend the intervention to other parents/total number of parents in the intervention arm), plus a 95% confidence interval.

    Time frame: PICU discharge (assessed up to 4 weeks)

Secondary outcomes

  1. Perceived Stress Scale (PSS)

    10-item measure of the degree to which participants appraise their situation as stressful; 5-point Likert scale (range 0- 40); scores 14-26 moderate and \>27 high levels of stress.

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

  2. Neuro-QOL Stigma Short-Form

    8-item measure of stigma associated with neurological illness; 5-point Likert scale; higher scores suggest more perceived stigma.

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

  3. Benefit Finding Scale

    14-item measure of areas of personal growth; 5-point Likert scale (range 10-49); higher scores suggest more benefit finding.

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

  4. Connor Davidson Resilience Scale (CD-RISC 10)

    10-item measure of self-perceived resilience; 5-point Likert scale (range 0-40); higher scores suggesting greater resilience.

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

  5. Human Connection Scale (HCS)

    16-item measure of sense of fondness, mutual understanding, caring, and trust with clinicians; 4-point Likert scale (range 16-64); higher scores suggest greater therapeutic alliance.

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

  6. Climate of Respect Evaluation in Intensive Care Units (CORE-ICU)

    21-item measure of 3 domains of respect as perceived by patients/surrogates in the ICU; 5-point Likert scale; higher scores on overall (range 7-42) and respectful behaviors (range 10-60) suggest greater respect, and lower respect on the disrespectful behaviors subsection (range 4-24).

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

  7. Interpersonal Reactivity Index (IRI) Empathetic Concern and Perspective-taking Subsections

    The 7-item empathic concern scale measures feelings of sympathy towards other people and is strongly correlated with measures of concern for others. The 7-item perspective-taking scale measures the tendency to adopt the psychological point of view of other people. Items are rated on a 4-point Likert scale and have very good internal consistency (Cronbach alpha=.81-.87) and validity in clinicians.

    Time frame: enrollment and PICU discharge (assessed up to 4 weeks)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Allen J, Brenner M, Hauer J, Molloy E, McDonald D. Severe Neurological Impairment: A delphi consensus-based definition. Eur J Paediatr Neurol. 2020 Nov;29:81-86. doi: 10.1016/j.ejpn.2020.09.001. Epub 2020 Sep 11. PubMed 32951992 ↗
  • Feudtner C, Kang TI, Hexem KR, Friedrichsdorf SJ, Osenga K, Siden H, Friebert SE, Hays RM, Dussel V, Wolfe J. Pediatric palliative care patients: a prospective multicenter cohort study. Pediatrics. 2011 Jun;127(6):1094-101. doi: 10.1542/peds.2010-3225. Epub 2011 May 9. PubMed 21555495 ↗
  • Berry JG, Poduri A, Bonkowsky JL, Zhou J, Graham DA, Welch C, Putney H, Srivastava R. Trends in resource utilization by children with neurological impairment in the United States inpatient health care system: a repeat cross-sectional study. PLoS Med. 2012 Jan;9(1):e1001158. doi: 10.1371/journal.pmed.1001158. Epub 2012 Jan 17. PubMed 22272190 ↗
  • Moreau JF, Fink EL, Hartman ME, Angus DC, Bell MJ, Linde-Zwirble WT, Watson RS. Hospitalizations of children with neurologic disorders in the United States. Pediatr Crit Care Med. 2013 Oct;14(8):801-10. doi: 10.1097/PCC.0b013e31828aa71f. PubMed 23842588 ↗
  • DeCourcey DD, Silverman M, Oladunjoye A, Balkin EM, Wolfe J. Patterns of Care at the End of Life for Children and Young Adults with Life-Threatening Complex Chronic Conditions. J Pediatr. 2018 Feb;193:196-203.e2. doi: 10.1016/j.jpeds.2017.09.078. Epub 2017 Nov 22. PubMed 29174080 ↗
  • Nolan R, Luther B, Young P, Murphy NA. Differing perceptions regarding quality of life and inpatient treatment goals for children with severe disabilities. Acad Pediatr. 2014 Nov-Dec;14(6):574-80. doi: 10.1016/j.acap.2014.02.012. Epub 2014 May 6. PubMed 24816425 ↗
  • Bogetz JF, Trowbridge A, Lewis H, Jonas D, Hauer J, Rosenberg AR. Forming Clinician-Parent Therapeutic Alliance for Children With Severe Neurologic Impairment. Hosp Pediatr. 2022 Mar 1;12(3):282-292. doi: 10.1542/hpeds.2021-006316. PubMed 35141756 ↗
  • Bogetz J, Ayala E, Anderson J, Morris L, Barton KS, Bradford MC, Zhou C, Yi-Frazier J, Watson RS, Rosenberg AR. A photo-narrative intervention protocol for clinicians and parents of children with severe neurological impairment in the PICU. Contemp Clin Trials Commun. 2025 Feb 11;44:101455. doi: 10.1016/j.conctc.2025.101455. eCollection 2025 Apr. PubMed 40034723 ↗

Study documents

  • Protocol and statistical analysis plan · Jun 2, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06208332
Lead sponsor
Seattle Children's Hospital
Responsible party
Jori Bogetz (Director, Research, Treuman Katz Center for Pediatric Bioethics and Palliative Care, Seattle Children's Hospital) — Principal investigator
First posted
Jan 17, 2024
Start date
Feb 10, 2025
Primary completion
Jan 1, 2027 (estimated)
Completion
May 15, 2027 (estimated)
Last update
Feb 18, 2026

Study contacts

Jori Bogetz, MD
Contact
jori.bogetz@seattlechildrens.org
206-884-0572
Jori Bogetz, MD
principal investigator · Seattle Children's Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion